NCT02034110 2023-08-21Efficacy and Safety of the Combination Therapy of Dabrafenib and Trametinib in Subjects With BRAF V600E- Mutated Rare CancersNovartisPhase 2 Completed206 enrolled 40 charts 2 FDA
NCT00623831 2022-10-25A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 AntigenLudwig Institute for Cancer ResearchPhase 1 Completed17 enrolled 14 charts
NCT02452424 2020-03-05A Combination Clinical Study of PLX3397 and Pembrolizumab To Treat Advanced Melanoma and Other Solid TumorsDaiichi SankyoPhase 1/2 Terminated78 enrolled 19 charts
NCT00428220 2019-06-27A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.PfizerPhase NA Completed223 enrolled 8 charts
NCT00538850 2014-03-05Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainINSYS Therapeutics IncPhase 3 Completed130 enrolled 9 charts